Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Nuke med intervention safe, effective against advanced liver cancer

Patients who have advanced liver cancer with blockage or narrowing of the blood vessel that brings blood to the liver from the intestines—i.e., portal vein thrombosis—are safely and effectively treated by interventional radiologists administering the isotope yttrium-90 (Y90) for radioembolization, according to a study conducted at Northwestern University and published online Dec. 7 in the Journal of Nuclear Medicine.

Keep risks of breast cancer from hormonal contraception in perspective

Medical research can gain traction in the mainstream media when findings make for catchy headlines. Last week, The New England Journal of Medicine reported hormonal contraception use can increase a woman’s risk of breast cancer. (Radiology Business tackled the subject.)

3D mammography is costly—but its benefits may more than pay the difference

While digital breast tomosynthesis (DBT), also known as 3D mammography, may cost more than digital mammography (DM) screenings at first, researchers believe it could reduce cancer screening costs in the long run. Findings were presented at the 2017 San Antonio Breast Cancer Symposium.

UltraSPECT’s New Ultra-Secured Gateway Delivers Impenetrable Defense Against Cybercriminals Seeking to Breach Nuke Med Systems

AUBURNDALE, MASS. — December 7, 2017 — UltraSPECT Inc., a leading provider of image reconstruction solutions supporting safer and faster nuclear cardiology and oncology exams, today announced the availability of a new add-on capability that vigorously protects nuclear imaging operations against every manner of breach, from basic malware to advanced persistent threats posed by the most determined hackers and cybercriminals.

Colon, breast, ovarian cancer survival rates lower in blacks than whites

Three new studies published in Cancer, the journal of the American Cancer Society, delivered mix news to black Americans. The good? Five-year survival rates for colon, breast and ovarian cancers have been improved—from 54.7 percent for 2001-2003 to 56.6 percent for 2004-2009.

RSNA 2017: Alternative approach to mammography shows promise

Dense breast tissue presents problems for detecting cancer—often leading to additional screenings after negative or questionable mammograms. But at RSNA 2017 in Chicago, a research team discussed abbreviated breast MRI (AB-MR), a new method to screen asymptomatic women with dense breasts.

Thumbnail

Evidence lacking in using radiography to diagnose constipation in children

Abdominal radiographs have been used to diagnose functional constipation in children and adolescents, despite a lack of evidence showing reliability. Researchers from the Boston Children’s Hospital examined how gastroenterologists use the images in diagnosing young patients.

Obesity, diabetes account for 5.6% of cancers, especially tumors in colon, gallbladder, liver

Radiologists and health imaging specialists trust in technology—improvements in image quality, efficiency and costs will likely continue. But the methods of cancer detection may be no match for individual health decisions.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.